Singapore : Singapore temporarily halted the use of two influenza vaccines as a precaution after the deaths of some domestically vaccinated influenza, making it one of the first countries to publicly announce the cessation of the vaccine.
South Korea reported that 48 people had been vaccinated against the flu and died as of Saturday, but said it would continue state-run vaccinations as no direct link was found between the deaths and vaccinations.
To date, no influenza-related deaths have been reported in Singapore, but the decision to discontinue use of SKYCellflu Quadrivalent and VaxigripTetra is a precautionary measure, the Ministry of Health and the Health Sciences Agency (HAS) said in a statement late Sunday.
The HSA is contacting Korean authorities for additional information while investigating whether the deceased is related to influenza vaccination.
SKYCellflu Quadrivalent is manufactured by SK Bioscience in Korea and sold locally by AJ Biologics, while VaxigripTetra is manufactured by Sanofi and sold locally by Sanofi Aventis.
Two other influenza vaccines introduced in Singapore for the Northern Hemisphere 2020/21 influenza season could continue to be used, Singapore health authorities said.